Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Completed · Phase 3 · Has a placebo group
Conditions studied: HIV-1 Infection
In brief
The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of switching abacavir/lamivudine (ABC/3TC) fixed-dose combination (FDC) tablets to emtricitabine/tenofovir alafenamide (F/TAF) FDC tablets versus maintaining ABC/3TC in human immunodeficiency virus type 1 (HIV-1) infected adults who are virologically suppressed on regimens containing ABC/3TC.
Key facts
- Study ID
- NCT02469246
- Run by
- Gilead Sciences
- People needed
- 567
- Starts
- 2015-06-29
- Expected to finish
- 2019-03-13
- Last updated by the study team
- 2019-10-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pacific Oaks Medical Group — Beverly Hills, California, United States
- University of California San Diego (UCSD) — La Jolla, California, United States
- Anthony Mills, MD, Inc. — Los Angeles, California, United States
- Peter J. Ruane, MD, Inc. — Los Angeles, California, United States
- Highland Hospital - Alameda Health System — Oakland, California, United States
- La Playa Medical Group and Clinical Research — San Diego, California, United States
- Capial Medical Associates — Washington D.C., District of Columbia, United States
- Dupont Circle Physician's Group — Washington D.C., District of Columbia, United States
- Whitman-Walker Health — Washington D.C., District of Columbia, United States
- Gary J. Richmond,M.D.,P.A. — Fort Lauderdale, Florida, United States
- Therafirst Medical Center — Fort Lauderdale, Florida, United States
- Midway Immunology and Research Center — Ft. Pierce, Florida, United States
- Orlando Immunology Center — Orlando, Florida, United States
- Triple O Research Institute PA — West Palm Beach, Florida, United States
- Atlanta ID Group — Atlanta, Georgia, United States
- Howard Brown Health Center — Chicago, Illinois, United States
- University of Louisville — Louisville, Kentucky, United States
- LSU Health Sciences Center — New Orleans, Louisiana, United States
- Be Well Medical Center — Berkley, Michigan, United States
- Hennepin County Medical Center — Minneapolis, Minnesota, United States
- The KC CARE Clinic — Kansas City, Missouri, United States
- Southampton Healthcare, Inc. — St Louis, Missouri, United States
- Saint Michael's Medical Center — Newark, New Jersey, United States
- South Jersey Infectious Disease — Somers Point, New Jersey, United States
- Spectrum Medical Group — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.